Children and adolescents with Tourette syndrome had a lower risk of relapses with investigational ecopipam, a phase III randomized withdrawal study showed. Compared with placebo, ...
Senior officials in the FDA's tobacco center were blindsided by a recent decision that opens the door to allowing more ...
States are monitoring additional people for potential hantavirus exposure, in many cases due to air travel, MedPage Today has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results